Japan is continuing to progress a broad genome analysis project that it is hoped will contribute to drug discovery and effective new therapies in areas including oncology and rare diseases, although some concerns have recently bubbled up around the initiative's real benefits to patients and data privacy.
The “All-Genome Analysis Project" (全ゲノム解析等実行計画) aims to build an information platform based on the analysis of around 100,000 genomes and...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?